GibbWRGLeesAJ. The relevance of the Lewy body in the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry1988;51:745–52.
2.
FearnleyJMLeesAJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain1991;114:2283–301.
3.
DexterDTJennerPSchapiraAHVMarsdenCD. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. Ann Neurol1992;32:S94–100.
4.
GoodPFOlanowCWPerlDP. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease. A LAMMA study. Brain Res1992;593:343–6.
5.
KastnerAHirschECLejeuneOJavoy-AgidFRascolOAgidY. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?J Neurochem1992;59:1080–9.
6.
OlanowCW. An introduction to the free radical hypothesis in Parkinson's disease. Ann Neurol1992;32:S2–9.
7.
RosenDRSiddiqueTPattersonDFiglewiczDASappHHentatiAMutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature1993;362:59–62.
8.
SingerTPRamsayRR. Biochemical reactions leading to parkinsonian symptoms elicited by MPTP. In: NagatsuTFisherAYoshidaM, eds. Basic, Clinical and Therapeutic Aspects of Alzheimer's and Parkinson's Disease. New York: Plenum Press, 1990:219–25.
9.
CleeterMJWCooperJMSchapiraAHV. Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J Neurochem1992;58:786–9.
10.
SchapiraAHVMannVMCooperJMKrigeDJennerPMarsdenCD. Mitochondrial function in Parkinson's disease. Ann Neurol1992;32:S116–24.
11.
ThomasPKCooperJMKingRHMWorkmanJMSchapiraAHVGoss-SampsonMAMyopathy in vitamin E deficient rats: muscle fibre necrosis associated with disturbances of mitochondrial function. J Anat1993;183:451–61.
12.
HartleyACooperJMSchapiraAHV. Iron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease. Brain Res1993;627:349–53.
13.
McGeerPLItagakiSAkiyamaHMcGeerEG. Rate of cell death in Parkinsonism indicates active neuropathological process. Ann Neurol1988;24:574–6.
14.
JennerPDexterDTSianJSchapiraAHVMarsdenCD. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. Ann Neurol1992;32:S82–7.
15.
MithöferKSandyMSSmithMTDi MonteD. Mitochondrial poisons cause depletion of reduced glutathione in isolated hepatocytes. Arch Biochem Biophys1992;295:132–6.
16.
WardCDDuvoisinRCInceSENuttJDEldridgeRCalneDB. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology1983;33:815–24.
17.
MarsdenCD. Parkinson's disease in twins. J Neurol Neurosurg Psychiatry1987;50:105–6.
18.
BurnDJMarkMHPlayfordEDMaraganoreDMZimmermanTRDuvoisonRCParkinson's disease in twins studied with 18F-dopa positron emission tomography. Neurology1992;42:1894–1900.
19.
GolbeLIDi IorioGBonavitaVMillerDCDuvoisinRC. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol1990;27:276–82.
20.
KollerWVetere-OverfieldBGrayCAlexanderCChinTDolezalJHassaneinRTannerC. Environmental risk factors in Parkinson's disease. Neurology1990;40:1218–21.
21.
ArmstrongMDalyAKCholertonSBatementDNIdleJR. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet1992;339:1017–18.
22.
SmithCADGoughACLeighPNSummersBAHardingAEMaranganoreDMDebrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet1992;339:1375–7.
23.
SteventonGBHeafieldMTEWaringRHWilliamsAC. Xenobiotic metabolism in Parkinson's disease. Neurology1989;39:883–7.
24.
SuzukiKMizunoYYoshidaM. Selective inhibition of complex I of the brain electron transport system by tetrahydroisoquinoline. Biochem Biophys Res Commun1989;162:1541–5.
25.
SayreLMWangFAroraPKRiachiNJHarikSIHoppelCL. Dopaminergic neurotoxicity in vivo and inhibition of mitochondrial respiration in vitro by possible endogenous pyridinium-like substances. J Neurochem1990;57:2106–15.